A Protective Allergy Vaccine Based on CpG- and Protamine-Containing PLGA Microparticles (Q59342624)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541735%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

title

A protective allergy vaccine based on CpG- and protamine-containing PLGA microparticles (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541735%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541735%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

4

Thomas M Kündig

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541735%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Stefan Fischer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541735%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Bruno Gander

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541735%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Pål Johansen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541735%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Julia M Martínez Gómez

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541735%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Hans P Merkle

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541735%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

31 May 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541735%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

published in

Pharmaceutical Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541735%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541735%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541735%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

1927-1935

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541735%20AND%20SRC:MED&resulttype=core&format=json

Anti-T-cell strategies in the treatment of allergic disease

31 December 2019

cites work

1 reference

12 December 2020

One-step preparation of polyelectrolyte-coated PLGA microparticles and their functionalization with model ligands

1 reference

12 December 2020

Effects of a hexameric deoxyriboguanosine run conjugation into CpG oligodeoxynucleotides on their immunostimulatory potentials

1 reference

12 December 2020

Modulation of allergic responses in mice by using biodegradable poly(lactide-co-glycolide) microspheres

1 reference

12 December 2020

Toll-like Receptors and Their Signaling Mechanisms

1 reference

12 December 2020

A Toll-like receptor recognizes bacterial DNA

1 reference

12 December 2020

Phosphorothioate backbone modification modulates macrophage activation by CpG DNA.

1 reference

12 December 2020

A recombinant allergen chimer as novel mucosal vaccine candidate for prevention of multi-sensitivities

1 reference

12 December 2020

Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals

1 reference

12 December 2020

Solvent extraction employing a static micromixer: a simple, robust and versatile technology for the microencapsulation of proteins

1 reference

12 December 2020

A simple modification of Blum's silver stain method allows for 30 minite detection of proteins in polyacrylamide gels

1 reference

12 December 2020

The enhanced effect of a hexameric deoxyriboguanosine run conjugation to CpG oligodeoxynucleotides on protection against allergic asthma

1 reference

12 December 2020

Oligodeoxynucleotide studies in primates: antisense and immune stimulatory indications

1 reference

12 December 2020

Peptide-based vaccines in the treatment of specific allergy

1 reference

12 December 2020

Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma.

1 reference

12 December 2020

Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis

1 reference

12 December 2020

CpG motifs in bacterial DNA and their immune effects

1 reference

12 December 2020

Immunological concepts of vaccine adjuvant activity

1 reference

12 December 2020

Long-term clinical efficacy of grass-pollen immunotherapy

1 reference

12 December 2020

A major allergen gene-fusion protein for potential usage in allergen-specific immunotherapy.

1 reference

12 December 2020

Induction of sustained and elevated immune responses to weakly immunogenic synthetic malarial peptides by encapsulation in biodegradable polymer microspheres

1 reference

12 December 2020

Nonmethylated CG motifs packaged into virus-like particles induce protective cytotoxic T cell responses in the absence of systemic side effects

1 reference

12 December 2020

CpG motifs in bacterial DNA trigger direct B-cell activation

1 reference

12 December 2020

Stability of polycationic complexes of an antisense oligonucleotide in rat small intestine homogenates

1 reference

12 December 2020

Modulation of airway inflammation by immunostimulatory CpG oligodeoxynucleotides in a murine model of allergic aspergillosis

1 reference

12 December 2020

Toll-like receptor ligands as adjuvants in allergen-specific immunotherapy

1 reference

12 December 2020

Heat denaturation, a simple method to improve the immunotherapeutic potential of allergens

1 reference

12 December 2020

Childhood and malaria vaccines combined in biodegradable microspheres produce immunity with synergistic interactions.

1 reference

12 December 2020

Biodegradable microspheres containing group B Streptococcus vaccine: immune response in mice

1 reference

12 December 2020

Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity.

1 reference

12 December 2020

Formulation and in vitro transfection efficiency of poly (D, L-lactide-co-glycolide) microspheres containing plasmid DNA for gene delivery

1 reference

12 December 2020

Mechanisms of immunotherapy.

1 reference

12 December 2020

An experimental divalent vaccine based on biodegradable microspheres induces protective immunity against tetanus and diphtheria

1 reference

12 December 2020

Monitoring allergen immunotherapy of pollen-allergic patients: the ratio of allergen-specific IgG4 to IgG1 correlates with clinical outcome

1 reference

12 December 2020

Changes in the antigenic and immunoglobulin E-binding properties of hen's egg albumin with the combination of heat and gamma irradiation treatment

1 reference

12 December 2020

Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. IV. Comparison of the safety and efficacy of two dosages of a high-molecular-weight allergoid

1 reference

12 December 2020

Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper

1 reference

12 December 2020

Pharmacokinetics of antisense oligonucleotides

1 reference

12 December 2020

Design, engineering and in vitro evaluation of MHC class-II targeting allergy vaccines.

1 reference

12 December 2020

In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes

1 reference

12 December 2020

10.1007/S11095-007-9318-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541735%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference